Clearpoint Neuro, Inc Appoints Ernesto Salegio as Vice President, Segment Leader Translational and Pre-Clinical Research
January 26, 2021 at 09:05 pm
ClearPoint Neuro, Inc. announced that Ernesto Salegio, PhD will join the Company as Vice President, Segment Leader Translational and Pre-Clinical Research as part of ClearPoint’s Biologics and Drug Delivery team on March 1, 2021. Dr. Salegio brings over 19 years of experience in translational neuroscience with direct pre-clinical central nervous system (CNS) expertise in the delivery of therapeutics to the brain and spinal cord, including over 16 years of gene therapy experience working with adeno-associated viral vectors (AAV).